CBT-I CBT-I Treatment Outcomes & Research Evidence

Question 1

Which organizations have endorsed CBT-I as the first-line treatment for chronic insomnia in adults?

Accepted Answer

American Academy of Sleep Medicine (AASM) and American College of Physicians (ACP)

Answer

Both the AASM and the ACP have issued clinical practice guidelines recommending CBT-I as the first-line treatment for chronic insomnia.

Question 2

Compared to sleep medication, CBT-I demonstrates:

Accepted Answer

Similar short-term and superior long-term effects with maintained gains after treatment ends

Answer

CBT-I produces comparable short-term effects and superior long-term outcomes because gains persist after treatment ends, unlike medication effects that diminish when discontinued.

Question 3

The typical response rate for CBT-I in randomized controlled trials is approximately:

Accepted Answer

70-80%

Answer

Meta-analyses consistently show 70-80% of patients achieve clinically meaningful improvements with CBT-I.

Question 4

The Insomnia Severity Index (ISI) clinical response is defined as a reduction of at least how many points?

Accepted Answer

6 points

Answer

A reduction of 6 or more points on the ISI is the accepted threshold for clinically meaningful response in insomnia treatment research.

Question 5

Which component of CBT-I has the strongest evidence base as a standalone intervention?

Accepted Answer

Stimulus control therapy

Answer

Stimulus control therapy has the most robust evidence as a single-component intervention, with decades of research demonstrating its efficacy.

(CBT-I) CBT Insomnia Certification Practice Test

(CBT-I) CBT Insomnia Certification Practice Test

CBT-I CBT-I Treatment Outcomes & Research Evidence